The US economy added fewer jobs in May compared with April, but economists say the labor market still looks healthy. The ...

For the full year, management raised its guidance, with revenue now at $3.151 billion-$3.163 billion from $3.129 ...

Healthcare stocks are only up 1.5% since the market bottom, and they remain down 2.6% for the year. That’s a major change ...

The US economy added 139,000 jobs in May, according to the latest report from the Bureau of Labor Statistics. The ...

You don't say how old your daughter is now. While she is under age 18, her eligibility for Medicaid will depend on your and your wife's income and assets - so if you accumulate savings, that could ...

OTTAWA--Canada and China have agreed to restore regular communications between the two countries following years of testy relations following Ottawa's role in the arrest of a senior Huawei ...

The second-day trading gain of about 45% for Circle's newly issued stock puts it many times over the average second-day return for larger IPOs over the past five years, according to Jay Ritter, a ...

Shares of Lululemon were down 20% on Friday afternoon. The steep drop arrived a day after the company lowered its full-year profit outlook, saying that U.S. tariffs on imports threatened to hit its ...

The core problem, Adams warns, is that hackers will target the AI agent's access codes rather than your credit card directly. Once they control the agent, they can create networks of fake shopping ...

The U.S. added 139,000 jobs in May, and the unemployment rate held steady at 4.2%. U.S. stocks rose after the jobs report showed hiring slowed in May, but by less than expected. ECB Has Won Battle ...

Apparel maker's stock falls 20% after company lowers its earnings forecast, citing trade war and a pullback in consumer spending. Wider stablecoin adoption, plus smaller partner payments, could offset ...

Omada is trading publicly after 14 years of providing support to patients with weight-related chronic illnesses. Leadership sees the current moment as the perfect time for an IPO, as GLP-1 drugs such ...